Application of Nanobiomedicine in Acute Lung Injury

Abstract

The respiratory system plays a crucial role in human life activities, and acute lung injury (ALI) is a highly fatal respiratory disease caused by a variety of reasons. At present, although several preclinical studies have demonstrated the efficacy of pharmacological interventions, supportive care and mechanical ventilation still remain the primary modalities for managing ALI, there are still no safe and effective treatments for ALI. With the rapid development of nanotechnology, a variety of nanobiomedicines with different structures and functional moieties have been well-designed based on their targeting ability and the pathophysiology of ALI. In this review, it summarizes the challenges faced by ALI therapy, introduces nanobiomedicines including liposomes, polymers, inorganic materials, and others to bring effective therapeutic effects for ALI, and discusses the research progress in recent years based on nanobiomedicine applied to acute lung injury. Finally, it provides a summary and prospect on the application of nanobiomedicine in ALI.